Amir Shojaei – Biography
Last update: March 27, 2026Executive profile
Amir was Executive Vice President and Chief Scientific Officer at AsclepiX Therapeutics, and Chief Executive Officer at TherOptix. Amir Shojaei joined Harrow in 2025.
Amir Shojaei is currentlyChief Scientific Officer at Harrow - View - Harrow org chart
Create your alert
to follow the career of Amir Shojaei.
Education
Amir Shojaei has a PhD in Pharmaceutical Sciences from University of the Pacific.
They have also studied at University of the Pacific :
Find more alumni from University of the Pacific
More about Amir Shojaei
Selected links
Do you need to know more about Amir Shojaei? More results.
Participate
Social media
- Amir Shojaei on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Amir Shojaei
The colleagues of Amir Shojaei
Company Colleagues
- At Harrow, Amir Shojaei has 25 colleagues including Mark Baum (CEO & Chairman), Lauren Silvernail (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Amir Shojaei has 22,991 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Amir Shojaei.
Get in Touch
Here are a few tips for establishing great contacts.
